David Jakeman - 30 Jan 2025 Form 4 Insider Report for CHIMERIX INC

Role: VP OF FINANCE AND ACCOUNTING
Signature: /s/ Michael Alrutz, Attorney-in-Fact
Issuer symbol: N/A
Transactions as of: 30 Jan 2025
Net transaction value: -$11,470
Form type: 4
Filing time: 31 Jan 2025, 16:40:39 UTC
Previous filing: 10 Jan 2025
Next filing: 14 Feb 2025
SEC filing: View on sec.gov

Key filing fact

David Jakeman filed Form 4 for CHIMERIX INC on 31 Jan 2025.

Key facts

This page summarizes David Jakeman's Form 4 filing for CHIMERIX INC.
1 reported transaction and 0 derivative rows are listed below.
Filing timestamp: 31 Jan 2025, 16:40.

Change

Previous filing in this sequence was filed on 10 Jan 2025.
Current net transaction value: -$11,470.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

See Original Filing

Reported transactions

CMRX transaction

Common Stock

Sale

Transaction value: $11,470
Shares: -2,800
Change %: -1.8%
Price: $4.10
Shares after: 149,287
Date: 30 Jan 2025
Ownership: Direct
Footnotes: F1, F2

^* indicates a reported price that failed the local validity check.

Explanation of Responses:

Id	Content
F1	The shares were sold in payment of the reporting person's tax liability incurred upon the vesting of shares subject to a restricted stock unit awards granted on January 22, 2021, January 18, 2022 and January 17, 2023. The sales of the shares were made pursuant to an automatic sell-to-cover arrangement adopted pursuant to Rule 10b5-1 under the Exchange Act in connection with the grant of such restricted stock unit awards.
F2	The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $4.08 to $4.11, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (2) to this Form 4.

Content

The shares were sold in payment of the reporting person's tax liability incurred upon the vesting of shares subject to a restricted stock unit awards granted on January 22, 2021, January 18, 2022 and January 17, 2023. The sales of the shares were made pursuant to an automatic sell-to-cover arrangement adopted pursuant to Rule 10b5-1 under the Exchange Act in connection with the grant of such restricted stock unit awards.

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $4.08 to $4.11, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (2) to this Form 4.